Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Body mass index (BMI) 27-37 kg/m2
Age 18-60 years old
Not taking anti-diabetes medication other than metformin
...
Body mass index (BMI) 27-37 kg/m2
Age 18-60 years old
Not taking anti-diabetes medication other than metformin
Male
Type 2 diabetes mellitus reasonably well controlled (HbA1c less than or equal to 58 mmol/mol) on diet therapy or metformin alone
Understand verbal and/or written explanation of the study requirements

Exclusion Criteria

Primary muscle disorders
Neurological disease e.g. epilepsy, Parkinsons disease
Other medications that may affect glucose tolerance (e.g. corticosteroids), muscle metabolism, or safety (e.g. anticoagulants)
...
Primary muscle disorders
Neurological disease e.g. epilepsy, Parkinsons disease
Other medications that may affect glucose tolerance (e.g. corticosteroids), muscle metabolism, or safety (e.g. anticoagulants)
Active respiratory disease
Anti-diabetes medication other than metformin
Clotting dysfunction
Metabolic diseases (stable treated hypothyroidism allowed)
Renal impairment (eGFR <60 ml/min)
Cerebrovascular disease
Malignancy (excluding localised basal and squamous cell skin cancer)
Active cardiovascular disease (current angina, myocardial infarct, or coronary artery surgery/angioplasty within 12 months)
Active gastrointestinal or liver disease
Any other conditions in addition to the above that the investigators consider may affect study measurements or safety

Summary

Conditions
Type 2 Diabetes
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Investigator)
  • Primary Purpose: Basic Science

Participation Requirements

Age
Between 18 years and 60 years
Gender
Only males

Inclusion Criteria

Body mass index (BMI) 27-37 kg/m2
Age 18-60 years old
Not taking anti-diabetes medication other than metformin
...
Body mass index (BMI) 27-37 kg/m2
Age 18-60 years old
Not taking anti-diabetes medication other than metformin
Male
Type 2 diabetes mellitus reasonably well controlled (HbA1c less than or equal to 58 mmol/mol) on diet therapy or metformin alone
Understand verbal and/or written explanation of the study requirements

Exclusion Criteria

Primary muscle disorders
Neurological disease e.g. epilepsy, Parkinsons disease
Other medications that may affect glucose tolerance (e.g. corticosteroids), muscle metabolism, or safety (e.g. anticoagulants)
...
Primary muscle disorders
Neurological disease e.g. epilepsy, Parkinsons disease
Other medications that may affect glucose tolerance (e.g. corticosteroids), muscle metabolism, or safety (e.g. anticoagulants)
Active respiratory disease
Anti-diabetes medication other than metformin
Clotting dysfunction
Metabolic diseases (stable treated hypothyroidism allowed)
Renal impairment (eGFR <60 ml/min)
Cerebrovascular disease
Malignancy (excluding localised basal and squamous cell skin cancer)
Active cardiovascular disease (current angina, myocardial infarct, or coronary artery surgery/angioplasty within 12 months)
Active gastrointestinal or liver disease
Any other conditions in addition to the above that the investigators consider may affect study measurements or safety

Tracking Information

NCT #
NCT02197299
Collaborators
Not Provided
Investigators
  • Principal Investigator: Francis B Stephens, PhD The University of Nottingham
  • Francis B Stephens, PhD The University of Nottingham
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024